Lv1
20 积分 2025-10-15 加入
Cross-target and cell-preferential CRISPR-Cas9 inhibition with carbohydrate-tagged oligonucleotides
11天前
已完结
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
1个月前
已完结
Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy
9个月前
已完结
Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis
10个月前
已完结
Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy
11个月前
已完结
皖公网安备34019202002308
